Published November 1, 2021 | Version v.1

Barks of Three Wild Pyrus Taxa: Phenolic Constituents, Antioxidant Activity, and in Vitro and in Silico Investigations of α-Amylase and α-Glucosidase Inhibition

  • 1. Department of Pharmacognosy, University of Belgrade – Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia
  • 2. Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia
  • 3. Natural History Museum, Njegoševa 51, 11000 Belgrade, Serbia
  • 4. Department of Pharmacognosy, University of Belgrade – Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia, e-mail: silvana.petrovic@pharmacy.bg.ac.rs

Description

Dry MeOH extracts of the twig barks of Pyrus communis subsp. pyrasterP. spinosa and their hybrid P.×jordanovii nothosubsp. velenovskyi, collected in wild in Serbia, were analyzed. By LC/MS, the contents of arbutin (99.9–131.0 mg/g), chlorogenic acid (2.2–6.3 mg/g), catechin (1.0–5.3 mg/g) and total dimeric and trimeric procyanidins (42.2–61.3 mg/g), including procyanidin B2 (8.9–17.2 mg/g), were determined. Colorimetrically, high contents of total phenolics (436.2–533.4 mg GAE/g) and tannins (339.4–425.7 mg GAE/g), as well as strong total antioxidant activities (FRAP values 4.5–5.9 mmol Fe2+/g), and DPPH (SC50=6.6–7.1 μg/ml) and hydroxyl radical (SC50=447.1–727.7 μg/ml) scavenging abilities were revealed. In vitro, all extracts exhibited notable inhibition of α-amylase (IC50=310.8–617.7 μg/ml) and particularly strong inhibition of α-glucosidase (IC50=2.1–3.7 μg/ml). Molecular docking predicted that among identified compounds procyanidin B2 is the best inhibitor of these carbohydrate-digesting enzymes. Obtained results showed that the barks of investigated Pyrus hybrid and its parent taxa have similar composition and bioactivity.

Notes

This work was supported by the Ministry of Education, Science and Technological Development of Republic of Serbia through Grant Agreement with University of Belgrade – Faculty of Pharmacy [grant number 451- 03-9/2021-14/200161] and Institute of Oncology and Radiology of Serbia [grant number 451-03-9/2021-14/ 200043].

Files

Restricted

The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/5636485">Log in</a> to check if you have access.

Request access

If you would like to request access to these files, please fill out the form below.

You need to satisfy these conditions in order for this request to be accepted:

Access to the article with institutional password only. 

You are currently not logged in. Do you have an account? Log in here

Additional details